The Expression of Recombinant Human Serum Albumin in the Mammary Gland of Transgenic Mice

Guihua Gong, Shuang-ting Han, Xiaoting Huang, Liqi Xie, Wei Zhang, Lei Xu, Youjia Hu
{"title":"The Expression of Recombinant Human Serum Albumin in the Mammary Gland of Transgenic Mice","authors":"Guihua Gong, Shuang-ting Han, Xiaoting Huang, Liqi Xie, Wei Zhang, Lei Xu, Youjia Hu","doi":"10.1055/s-0041-1730985","DOIUrl":null,"url":null,"abstract":"Abstract Human serum albumin (HSA) is widely used in the clinic for the treatment of several diseases in large amount each year. With the increasing demands of HSA in clinic and limited blood resource, recombinant HSA (rHSA) is becoming an attractive and alternative source for HSA production. In this study, we aimed to express rHSA in the mammary glands of transgenic mice by using a tissue-specific promoter and other regulatory elements. An rHSA expression vector was constructed bearing the cDNA and first intron of HSA under the control of bovine αs1-casein promoter with a 2 × chicken β-globin insulator in the front. Transgenic mice were generated and reverse transcription polymerase chain reaction showed that rHSA was expressed only in the mammary gland, indicating the tissue specificity of the bovine αs1-casein promoter in directing transgene transcription in transgenic mice. Enzyme-linked immunosorbent assay test showed that rHSA was successfully secreted into the milk of transgenic mice with the highest level at 1.98 ± 0.12 g/L. Our results indicate the ability of the bovine αs1-casein promoter to induce successful expression of rHSA in the mammary gland of transgenic mice.","PeriodicalId":19767,"journal":{"name":"Pharmaceutical Fronts","volume":"141 1","pages":"e30 - e37"},"PeriodicalIF":0.0000,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Fronts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0041-1730985","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract Human serum albumin (HSA) is widely used in the clinic for the treatment of several diseases in large amount each year. With the increasing demands of HSA in clinic and limited blood resource, recombinant HSA (rHSA) is becoming an attractive and alternative source for HSA production. In this study, we aimed to express rHSA in the mammary glands of transgenic mice by using a tissue-specific promoter and other regulatory elements. An rHSA expression vector was constructed bearing the cDNA and first intron of HSA under the control of bovine αs1-casein promoter with a 2 × chicken β-globin insulator in the front. Transgenic mice were generated and reverse transcription polymerase chain reaction showed that rHSA was expressed only in the mammary gland, indicating the tissue specificity of the bovine αs1-casein promoter in directing transgene transcription in transgenic mice. Enzyme-linked immunosorbent assay test showed that rHSA was successfully secreted into the milk of transgenic mice with the highest level at 1.98 ± 0.12 g/L. Our results indicate the ability of the bovine αs1-casein promoter to induce successful expression of rHSA in the mammary gland of transgenic mice.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
重组人血清白蛋白在转基因小鼠乳腺中的表达
摘要人血清白蛋白(HSA)广泛应用于临床,每年大量治疗多种疾病。随着临床对人血蛋白需求的增加和血液资源的限制,重组人血蛋白(rHSA)正成为一种有吸引力的替代人血蛋白生产来源。在本研究中,我们旨在利用组织特异性启动子和其他调控元件在转基因小鼠的乳腺中表达rHSA。在牛αs1-酪蛋白启动子控制下,以2 ×鸡β-珠蛋白绝缘子为载体,构建了含cDNA和HSA第一内含子的rHSA表达载体。反转录聚合酶链反应显示,rHSA仅在乳腺中表达,说明牛αs1-酪蛋白启动子在转基因小鼠中具有指导转基因转录的组织特异性。酶联免疫吸附试验表明,rHSA成功分泌到转基因小鼠乳中,最高水平为1.98±0.12 g/L。我们的研究结果表明,牛αs1酪蛋白启动子能够诱导rHSA在转基因小鼠乳腺中成功表达。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
24
审稿时长
15 weeks
期刊最新文献
Recent Advances in Mitochondrial Pyruvate Carrier Inhibitors Discovery of a Novel Benzimidazole Necroptosis Inhibitor from an In-House Compound Library Research Strategies for Precise Manipulation of Micro/Nanoparticle Drug Delivery Systems Using Microfluidic Technology: A Review Advances in Tumor Targeting Biomimetic Drug Delivery Systems: A Promising Approach for Antitumor Therapy 3D Printing Pharmaceuticals: Current Status and Future Opportunities
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1